It's official: GlaxoSmithKline's passing the chairman reins to Jonathan Symonds, an AstraZeneca and Novartis veteran, as of Sept. 1. That'll give him plenty of time to help steer GSK's consumer health hive-off.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,